MARKET

ALPMF

ALPMF

Astellas Pharma
OTCPK
13.45
NaN%
Closed 09:30 06/30 EDT
OPEN
--
PREV CLOSE
13.45
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
41.25
52 WEEK LOW
13.45
MARKET CAP
24.10B
P/E (TTM)
13.12
1D
5D
1M
3M
1Y
5Y
1D
J.P. Morgan Sticks to Their Hold Rating for Astellas Pharma (ALPMF)
TipRanks · 1d ago
Weekly Report: what happened at ALPMF last week (0622-0626)?
Weekly Report · 1d ago
Merck gains EU approval of Keyruda, Padcev combo for bladder cancer
Seeking Alpha · 6d ago
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Benzinga · 06/23 17:46
Sangamo files for restructuring, plans asset sales to Lilly, Astellas
TipRanks · 06/23 16:21
Weekly Report: what happened at ALPMF last week (0615-0619)?
Weekly Report · 06/22 09:57
Weekly Report: what happened at ALPMF last week (0608-0612)?
Weekly Report · 06/15 09:58
Astellas Wraps Up Real-World Safety Study on Smyraf, Clarifying RA Market Outlook
TipRanks · 06/10 16:31
More
About ALPMF
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.

Webull offers Astellas Pharma Inc stock information, including OTCPK: ALPMF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ALPMF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ALPMF stock methods without spending real money on the virtual paper trading platform.